A New Age of Personalised Medicine at the 5th BioCeuticals Research Symposium
A New Age of Personalised Medicine at the 5th BioCeuticals Research Symposium
21 – 23 April, 2017
Hilton Hotel, Sydney
The future of personalised medicine is set to be a focus by world-leading functional medicine experts at the 5th BioCeuticals Research Symposium in April 2017, announced today by Australia’s leading provider of nutritional and therapeutic supplements, BioCeuticals.
The study of the human genome has opened a window, providing compelling insights into the relationship between an individual’s biological character and environmental influences. The concept of personalised medicine is now gaining traction as a unique and improved approach to practice, with decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.
We know now that exposure to toxins, excess consumption of sugars and carbs, stress and other factors that typically are known to cause chronic illness are not the only cause for disease. Rather, through personalised medicine, we are learning that vulnerability to illness is largely dependent on how each individual deals and reacts to these factors.
Under the theme of The Age Of Personalised Medicine: Improved Clinical Insights for Better Patient Outcomes, the 5th BioCeuticals Research Symposium aims to be the event calendar highlight of the integrative medicine industry, reaching up to 500 delegates, and will see the new-age question answered – “why do some people get sick when exposed to certain risks, while others seem to be largely unaffected?”
Delegates will be able to learn how to move away from the “trial-and-error” approach that typically leads to patient dissatisfaction, and instead will learn how to distinguish between patients who are most likely to benefit from specific treatments, and patients who are not.
BioCeuticals Managing Director, Nathan Cheong, said the much celebrated three-day masterclass format will focus on how advances in functional medicine can be applied in clinic to support the individual needs of the patient.
“Personalised medicine is the new age of integrative healthcare. Research and clinical protocols are evolving rapidly. It is critical that integrative practitioners are able to apply this knowledge to suit the unique needs of their patients,” Mr Cheong said.
“We’re extremely excited to be hosting four renowned international speakers at the 5th BioCeuticals Symposium next April, which will offer integrative healthcare practitioners the opportunity to learn how to adapt new and proven clinical approaches in their practice.
“We hope the Symposium will further act as a portal for people who want up-to-date information of the latest advances in the field, and an opportunity to learn from the best in integrative medicine,” said Mr Cheong.
Recently BioCeuticals won the Complementary Medicines Australia (CMA) award for Most Outstanding Contribution to Research, Education or Training, and is excited to be offering delegates of the Symposium another opportunity to further excel in their education and training.
Key speakers at the 5th BioCeuticals Symposium include:
- Robert H. Lustig, MD MSL (USA) is an internationally respected neuro-endocrinologist and expert in regulation of energy balance by the central nervous system. Dr Lustig is renowned for his work to combat the global obesity epidemic in children and adults and is one of the leaders of the international “anti-sugar” movement to improve human health. Author of Fat Chance: The Bitter Truth about Sugar, The Fat Chance Cookbook, and the soon-to-be released The Agony of Ecstasy, Dr Lustig is also President of the non-profit Institute for Responsible Nutrition which is devoted to improving the global food supply.
- Steven Sandberg-Lewis, ND DHANP (USA) is a renowned specialist in gastrointestinal disorders, with a special interest in Irritable Bowel Syndrome (IBS), Small Intestine Bacterial Overgrowth (SIBO) and bile reflux Gastro Oesophageal Reflux Disease (GORD). Author and co-author of several Townsend Letter award winning articles and practicing naturopathic physician. He was named one of the “Top Docs” in Portland monthly magazine’s yearly healthcare issue in 2014 and in 2015 was inducted into the OANP/NUNM Hall of Fame.
- Christopher W. Shade, BS MS PhD (USA) is a globally recognized expert on mercury and liposomal delivery systems. He is an international trainer and educator on mercury, heavy metals and the human detoxification system and developed the patented liquid chromatographic mercury speciation technology used at Quicksilver Scientific. Dr. Shade’s current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals, such as liposomes and micro-emulsion systems to address the growing need of high quality, affordable detoxification solutions.
- Denise Furness, PhD BSc RNutr REP (AUS) is a molecular geneticist, registered nutritionist and registered exercise professional. Her research focus is folate nutrigenomics, methylation and DNA damage in relation to pregnancy outcomes. She has published her work in peer reviewed medical journals and regularly presents at national and international conferences. She has a special interest in helping couples achieve optimum health and wellness to improve their chances for natural conception and healthy pregnancy outcomes.
EARN CPE & CPD ACCREDITATION
BioCeuticals has applied for CPE/ CPD Accreditation for the Symposium. More information on the qualifying associations and point’s breakdown will be provided soon.
Healthcare practitioners who would like to attend the Symposium can register to receive the Early-Bird Rate of $780.00 (valid until 10 March 2017).
ABOUT BIOCEUTICALS
BioCeuticals is at the forefront of evidence-based Integrative Medicine, being a proud sponsor 11 key clinical trials, 5 of which are in primary healthcare facilities. BioCeuticals is committed to helping educate healthcare professionals on research and its practical application for better outcomes for their patients.
Renowned for manufacturing and delivering premium quality integrative medicines to healthcare practitioners, BioCeuticals aims to consistently raise the standards of complementary therapies.
BioCeuticals is a proud advocate of Corporate Social Responsibility initiatives, with a CSR Committee tasked with ensuring that activities within the company are community-focused and give back where they can.
Find out more and register at the BioCeuticals website.